isovalerylshikonin and Sepsis

isovalerylshikonin has been researched along with Sepsis* in 1 studies

Other Studies

1 other study(ies) available for isovalerylshikonin and Sepsis

Article	Year
Isovalerylshikonin, a new resistance-modifying agent from Arnebia euchroma, supresses antimicrobial resistance of drug-resistant Staphylococcus aureus. International journal of antimicrobial agents, 2019, Volume: 53, Issue:1 Topics: Animals; Anti-Bacterial Agents; Boraginaceae; Drug Synergism; Mice; Microbial Sensitivity Tests; Naphthoquinones; Pentanoic Acids; Peritonitis; Sepsis; Staphylococcal Infections; Staphylococcus aureus	2019

Article

Year

Isovalerylshikonin, a new resistance-modifying agent from Arnebia euchroma, supresses antimicrobial resistance of drug-resistant Staphylococcus aureus.

International journal of antimicrobial agents, 2019, Volume: 53, Issue:1

Topics: Animals; Anti-Bacterial Agents; Boraginaceae; Drug Synergism; Mice; Microbial Sensitivity Tests; Naphthoquinones; Pentanoic Acids; Peritonitis; Sepsis; Staphylococcal Infections; Staphylococcus aureus

2019